Compounds > drospirenone and ethinyl estradiol combination
Page last updated: 2024-09-04

drospirenone and ethinyl estradiol combination and rofecoxib

drospirenone and ethinyl estradiol combination has been researched along with rofecoxib in 1 studies

Compound Research Comparison

Studies
(drospirenone and ethinyl estradiol combination)		Trials
(drospirenone and ethinyl estradiol combination)		Recent Studies (post-2010)
(drospirenone and ethinyl estradiol combination)		Studies
(rofecoxib)		Trials
(rofecoxib)		Recent Studies (post-2010) (rofecoxib)
130511021,914307163

Protein Interaction Comparison

ProteinTaxonomydrospirenone and ethinyl estradiol combination (IC50)rofecoxib (IC50)
Prostaglandin G/H synthase 2 Bos taurus (cattle)0.43
Cytochrome c oxidase subunit 2Homo sapiens (human)1.51
Prostaglandin G/H synthase 1Ovis aries (sheep)0.5
Seed linoleate 13S-lipoxygenase-1Glycine max (soybean)0.5
Calpain-2 catalytic subunitHomo sapiens (human)0.02
Prostaglandin G/H synthase 1Homo sapiens (human)1.8
Prostaglandin G/H synthase 2Homo sapiens (human)0.3602
Prostaglandin G/H synthase 2 Rattus norvegicus (Norway rat)0.76
Prostaglandin G/H synthase 2Ovis aries (sheep)0.486
Prostaglandin G/H synthase 2Mus musculus (house mouse)0.036
Sodium-dependent serotonin transporterMacaca mulatta (Rhesus monkey)0.5

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bourke, J; Roper, S1

Other Studies

1 other study(ies) available for drospirenone and ethinyl estradiol combination and rofecoxib

ArticleYear
In with the new: the determinants of prescribing innovation by general practitioners in Ireland.
    The European journal of health economics : HEPAC : health economics in prevention and care, 2012, Volume: 13, Issue:4

    Topics: Age Factors; Androstenes; Citalopram; Drug Prescriptions; Drug Utilization; Ethinyl Estradiol; General Practitioners; Humans; Information Dissemination; Insurance Claim Review; Ireland; Lactones; Loratadine; Nicotine; Omeprazole; Practice Patterns, Physicians'; Residence Characteristics; Sulfones; Therapies, Investigational; Time Factors

2012